Top Markets
Coin of the day
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
Rank in Stocks #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
Share Price
$0.94
Last synced: 2025-02-28
Market Cap
$2.73M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Fresh Tracks Therapeutics, Inc. (FRTX)

Category

Operating Margin for Fresh Tracks Therapeutics, Inc. (FRTX)
Operating Margin as of August 2026 TTM: -79.44%
According to Fresh Tracks Therapeutics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -79.44%. At the end of 2022 the company had an Operating Margin of -310.15%.
Operating Margin history for Fresh Tracks Therapeutics, Inc. from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -79.44% 0.00%
2023 -79.44% -74.39%
2022 -310.15% -96.89%
2021 -9,961.39% 765.26%
2020 -1,151.26% 272.50%
2019 -309.06% -74.48%
2018 -1,211.22% 1,150.36%
2017 -96.87% 53.40%
2016 -63.15% 40.68%
2015 -44.89% -58.91%
2014 -109.26% -73.10%
2013 -406.22% 203.69%
2012 -133.76% 413.28%
2011 -26.06% -92.73%
2010 -358.34% 59.02%
2009 -225.34% -51.99%
2008 -469.37% -35.74%
2007 -730.44% 307.57%
2006 -179.22% -16.13%
2005 -213.70% 23.63%
2004 -172.86% -46.50%
2003 -323.12% -28.41%
2002 -451.36% 197.75%
2001 -151.59% -28.52%
2000 -212.06% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -100.49%
US
28.81% -100.36%
NL
0.00% -
CH
0.00% -
KR
31.23% -100.39%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.